Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-18-001815
Filing Date
2018-04-27
Accepted
2018-04-27 17:04:53
Documents
3
Period of Report
2018-06-25
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT txmd-def14a_062518.htm DEF 14A 656303
2 GRAPHIC txmd001.jpg GRAPHIC 22792
3 GRAPHIC proxycard001.jpg GRAPHIC 3770
  Complete submission text file 0001387131-18-001815.txt   694506
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 18785343
SIC: 2834 Pharmaceutical Preparations